Evaluation of ocular pharmacokinetics of ck41016, a novel drug candidate for the treatment of age-related macular degeneration

• In: Poster presentation
• At: Seoul (South Korea) (2017)
• Type: Poster
• Poster code: POS-PAA-005
• By: CHO, Hea-Young (CHA University, College of Pharmacy, Seongnam-si, Korea, Republic Of)
• Co-author(s): Hwajin Shin: College of Pharmacy, CHA University, Seongnam-si, Korea, Republic Of
  Seong-Moon Cheon: College of Pharmacy, CHA University, Seongnam-si, Korea, Republic Of
  Sook-Jin Kim: College of Pharmacy, CHA University, Seongnam-si, Korea, Republic Of
  Yong-Bok Lee: College of Pharmacy, Chonnam National University, Gwangju, Korea, Republic Of
  Hea-Young Cho: College of Pharmacy, CHA University, Seongnam-si, Korea, Republic Of
  
• Abstract:

  Background

  CK41016 as a new drug candidate is a breakthrough for age-related macular degeneration (AMD). AMD damages to the macula of the retina and causes adult blindness. Current therapy of AMD is an intravitreal injection and can cause endophthalmitis, retinal detachment and increased intraocular pressure. Therefore, topical and non-invasive

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login